A total of 23 studies from 11 registries in eight countries spanning Europe, North America, and Oceania were identified and included in the review. Most studies were retrospective in nature and ...

Between July 1997 and December 2019, Hispanic women, living in the United States or in Latin America, enrolled in the Clinical Cancer Genomics Community Research Network registry were prospectively ...

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial ...

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice This open-label, ...

Willingness of Women at Increased Risk of Breast Cancer to Participate in Prevention Trials Between April 2022 and October 2023, a survey was conducted among adult patients treated for cancer in the ...

Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women Among 29 participants from 10 African institutions, PM skills improved after training by 16.6% compared with ...

Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial ...

Cancer recurrence is an important long-term outcome of cancer survivors that is often not routinely collected and recorded by population-based registries. In this study, we review population-based ...

Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care WTP in BC prevention trials was the highest for women with known genetic risk and for interventions involving a behavior ...